FRIMOUSSE DRUGSTORE : revenue, balance sheet and financial ratios

FRIMOUSSE DRUGSTORE is a French company founded 13 years ago, specialized in the sector Commerce de détail d'habillement en magasin spécialisé. Based in RENNES (35000), this company of category PME shows in 2022 a revenue of 2.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - FRIMOUSSE DRUGSTORE (SIREN 792234288)
Indicator 2022 2021 2020 2017
Revenue 2 237 822 € 1 873 837 € 1 096 660 € N/C
Net income 211 164 € 300 198 € 92 715 € 68 096 €
EBITDA 247 289 € 396 749 € 211 014 € N/C
Net margin 9.4% 16.0% 8.5% N/C

Revenue and income statement

In 2022, FRIMOUSSE DRUGSTORE achieves revenue of 2.2 M€. Over the period 2020-2022, the company shows strong growth with a CAGR (compound annual growth rate) of +42.8%. Vs 2021, growth of +19% (1.9 M€ -> 2.2 M€). After deducting consumption (1.4 M€), gross margin stands at 880 k€, i.e. a rate of 39%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 247 k€, representing 11.1% of revenue. Warning negative scissor effect: despite revenue change (+19%), EBITDA varies by -38%, reducing margin by 10.1 pts. This reflects costs rising faster than revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 211 k€, i.e. 9.4% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2022) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

2 237 822 €

Gross margin (2022) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

880 496 €

EBITDA (2022) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

247 289 €

EBIT (2022) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

268 341 €

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

211 164 €

EBITDA margin (2022) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

11.0%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 67%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.9 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 8.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

67.297%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

46.588%

Cash flow / Revenue (2022) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

8.449%

Repayment capacity (2022) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

2.852

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

28.7%

Solvency indicators evolution
FRIMOUSSE DRUGSTORE

Sector positioning

Debt ratio
67.3 2022
2020
2021
2022
Q1: 1.31
Med: 38.04
Q3: 125.5
Average

In 2022, the debt ratio of FRIMOUSSE DRUGSTORE (67.30) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
46.59% 2022
2020
2021
2022
Q1: 12.92%
Med: 35.59%
Q3: 59.39%
Good +8 pts over 3 years

In 2022, the financial autonomy of FRIMOUSSE DRUGSTORE (46.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
2.85 years 2022
2020
2021
2022
Q1: 0.0 years
Med: 0.48 years
Q3: 3.26 years
Average +8 pts over 3 years

In 2022, the repayment capacity of FRIMOUSSE DRUGSTORE (2.85) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 323.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.2x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

323.441

Interest coverage (2022) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.2

Liquidity indicators evolution
FRIMOUSSE DRUGSTORE

Sector positioning

Liquidity ratio
323.44 2022
2020
2021
2022
Q1: 118.94
Med: 209.07
Q3: 369.86
Good +11 pts over 3 years

In 2022, the liquidity ratio of FRIMOUSSE DRUGSTORE (323.44) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
0.2x 2022
2020
2021
2022
Q1: 0.0x
Med: 0.32x
Q3: 3.45x
Average -15 pts over 3 years

In 2022, the interest coverage of FRIMOUSSE DRUGSTORE (0.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 1 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 50 days. Excellent situation: suppliers finance 49 days of the operating cycle (retail model). Inventory turnover is 177 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 149 days of revenue, i.e. 929 k€ to permanently finance.

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

928 920 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

1 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

50 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

177 j

WCR in days of revenue (2022) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

149 j

WCR and payment terms evolution
FRIMOUSSE DRUGSTORE

Positioning of FRIMOUSSE DRUGSTORE in its sector

Comparison with sector Commerce de détail d'habillement en magasin spécialisé

Valuation estimate

Based on 75 transactions of similar company sales in 2022, the value of FRIMOUSSE DRUGSTORE is estimated at 761 946 € (range 335 877€ - 1 548 596€). With an EBITDA of 247 289€, the sector multiple of 2.5x is applied. The price/revenue ratio is 0.52x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2022
75 tx
335k€ 761k€ 1548k€
761 946 € Range: 335 877€ - 1 548 596€
NAF 5 année 2022

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
247 289 € × 2.5x
Estimation 626 460 €
332 422€ - 1 387 748€
Revenue Multiple 30%
2 237 822 € × 0.52x
Estimation 1 168 608 €
438 178€ - 2 065 115€
Net Income Multiple 20%
211 164 € × 2.3x
Estimation 490 668 €
191 066€ - 1 175 943€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 75 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail d'habillement en magasin spécialisé)

Compare FRIMOUSSE DRUGSTORE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail d'habillement en magasin spécialisé

Frequently asked questions about FRIMOUSSE DRUGSTORE

What is the revenue of FRIMOUSSE DRUGSTORE ?

The revenue of FRIMOUSSE DRUGSTORE in 2022 is 2.2 M€.

Is FRIMOUSSE DRUGSTORE profitable?

Yes, FRIMOUSSE DRUGSTORE generated a net profit of 211 k€ in 2022.

Where is the headquarters of FRIMOUSSE DRUGSTORE ?

The headquarters of FRIMOUSSE DRUGSTORE is located in RENNES (35000), in the department Ille-et-Vilaine.

Where to find the tax return of FRIMOUSSE DRUGSTORE ?

The tax return of FRIMOUSSE DRUGSTORE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does FRIMOUSSE DRUGSTORE operate?

FRIMOUSSE DRUGSTORE operates in the sector Commerce de détail d'habillement en magasin spécialisé (NAF code 47.71Z). See the 'Sector positioning' section above to compare the company with its competitors.